Risk of Cancer in Patients with Psoriasis on Biologic Therapies: A Systematic Review.

about

Risk of Cancer in Patients with Psoriasis on Biologic Therapies: A Systematic Review.

Item

http://www.wikidata.org/entity/Q38672588

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Risk of Cancer in Patients with Psoriasis on Biologic Therapies: A Systematic Review.

@en

type

Item

label

Risk of Cancer in Patients with Psoriasis on Biologic Therapies: A Systematic Review.

@en

prefLabel

Risk of Cancer in Patients with Psoriasis on Biologic Therapies: A Systematic Review.

@en

P1476

Risk of cancer in patients with psoriasis on biological therapies: a systematic review

@en

P2093

C E Kleyn

http://www.w3.org/2001/XMLSchema#string

K Kelley

http://www.w3.org/2001/XMLSchema#string

L S Exton

http://www.w3.org/2001/XMLSchema#string

P2860

Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: a randomised trial

Three-year registry data on biological treatment for psoriasis: the influence of patient characteristics on treatment outcome.

Risk of developing a subsequent nonmelanoma skin cancer in patients with a history of nonmelanoma skin cancer: a critical review of the literature and meta-analysis.

Carcinogenic risks of psoralen UV-A therapy and narrowband UV-B therapy in chronic plaque psoriasis: a systematic literature review.

Risk of solid cancer in patients exposed to anti-tumour necrosis factor therapy: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis.

Inflammation and cancer: how hot is the link?

Adalimumab: long-term safety in 23 458 patients from global clinical trials in rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing spondylitis, psoriatic arthritis, psoriasis and Crohn's disease.

Risk of invasive melanoma in patients with rheumatoid arthritis treated with biologics: results from a collaborative project of 11 European biologic registers

Guidelines of care for the management of psoriasis and psoriatic arthritis: section 6. Guidelines of care for the treatment of psoriasis and psoriatic arthritis: case-based presentations and evidence-based conclusions.

The long-term safety of adalimumab treatment in moderate to severe psoriasis: a comprehensive analysis of all adalimumab exposure in all clinical trials.

P304

103-113

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

meta-analysis

P356

10.1111/BJD.15830

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

178

http://www.w3.org/2001/XMLSchema#string

P50

Catherine H Smith

Kayleigh J Mason

E Peleva

P577

2017-12-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28722163

http://www.w3.org/2001/XMLSchema#string